Physician

Marie S Tuttle, M.D.

According to 2025 Medicare claims, Marie Tuttle, M.D. (NPI: 1356531438) practices dermatology in the St. George, UT market, with the plurality of this provider's patient population coming from Washington, UT. This provider's primary affiliated billing organization is TUTTLE DERMATOLOGY PC (NPI: 1598261869; TIN: 824785085) and primary practice location at 84790-8049.

Tuttle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,274 traditional Medicare patients, billed 17,939 HCPCS/CPT codes, and received $238,096 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,071 prescription claims across 469 beneficiaries totaling $137,779 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). Open Payments data shows 31 records totaling $560. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $45,139 to $238,096. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $52,865 to $137,779. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$137K$274K2015 Medicare payment: $45,139 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $117,340 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $144,512 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $188,789 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $238,541 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $226,033 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $273,940 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $267,031 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $262,797 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $238,096 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015214705$45,139
20164382,295$117,340
20175703,660$144,512
20188344,499$188,789
20191,0658,242$238,541
20201,10810,446$226,033
20211,37212,012$273,940
20221,41510,034$267,031
20231,38713,567$262,797
20241,27417,939$238,096

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$96K$192K2015 Drug cost: $52,865 (USD; Tot_Drug_Cst)2016 Drug cost: $79,502 (USD; Tot_Drug_Cst)2017 Drug cost: $58,153 (USD; Tot_Drug_Cst)2018 Drug cost: $53,271 (USD; Tot_Drug_Cst)2019 Drug cost: $122,918 (USD; Tot_Drug_Cst)2020 Drug cost: $121,687 (USD; Tot_Drug_Cst)2021 Drug cost: $75,078 (USD; Tot_Drug_Cst)2022 Drug cost: $65,994 (USD; Tot_Drug_Cst)2023 Drug cost: $191,637 (USD; Tot_Drug_Cst)2024 Drug cost: $137,779 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201599204$52,865
2016179465$79,502
2017191473$58,153
2018275591$53,271
2019371878$122,918
20204191,018$121,687
2021421976$75,078
2022393814$65,994
2023450996$191,637
20244691,071$137,779

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth162171$55
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more9751,395$53
17000Destruction of precancer skin growth, 1 growth8131,034$35
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more269292$33
17003Destruction of precancer skin growth, 2-14 growths6333,407$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Sensoready (2 Pens)Secukinumab12336$86,487
KetoconazoleKetoconazole2497,884$4,170
Clobetasol PropionateClobetasol Propionate1263,485$3,532
TretinoinTretinoin16482$1,575
ValacyclovirValacyclovir Hcl671,156$1,175

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.31$560ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marie S. Tuttle, M.D.?

Tedicare shows public-source Medicare data for Marie S. Tuttle, M.D. (NPI 1356531438), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marie S. Tuttle, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Marie S. Tuttle, M.D.?

Marie S. Tuttle, M.D. is linked to TUTTLE DERMATOLOGY PC (billing NPI 1598261869) in the available physician profile data.

Does Marie S. Tuttle, M.D. have Open Payments data?

Marie S. Tuttle, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.